Zhang R - Search Results

1

Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action.

Wang W, Rayburn ER, Zhao Y, Wang H, Zhang R. Wang W, et al. Among authors: zhang r. Cancer Lett. 2009 Jun 18;278(2):241-248. doi: 10.1016/j.canlet.2009.01.005. Epub 2009 Feb 8. Cancer Lett. 2009. PMID: 19203832 Free PMC article.

2

Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.

Wang H, Wang S, Nan L, Yu D, Agrawal S, Zhang R. Wang H, et al. Among authors: zhang r. Int J Oncol. 2002 Apr;20(4):745-52. Int J Oncol. 2002. PMID: 11894120

3

Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.

Wang H, Oliver P, Nan L, Wang S, Wang Z, Rhie JK, Zhang R, Hill DL. Wang H, et al. Among authors: zhang r. Cancer Chemother Pharmacol. 2002 May;49(5):419-24. doi: 10.1007/s00280-002-0433-7. Epub 2002 Mar 8. Cancer Chemother Pharmacol. 2002. PMID: 11976837

4

Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.

Prasad G, Wang H, Agrawal S, Zhang R. Prasad G, et al. Among authors: zhang r. Anticancer Res. 2002 Jan-Feb;22(1A):107-16. Anticancer Res. 2002. PMID: 12017271

5

Antisense oligonucleotide targeted to RIalpha subunit of cAMP-dependent protein kinase (GEM231) enhances therapeutic effectiveness of cancer chemotherapeutic agent irinotecan in nude mice bearing human cancer xenografts: in vivo synergistic activity, pharmacokinetics and host toxicity.

Wang H, Hang J, Shi Z, Li M, Yu D, Kandimalla ER, Agrawal S, Zhang R. Wang H, et al. Among authors: zhang r. Int J Oncol. 2002 Jul;21(1):73-80. Int J Oncol. 2002. PMID: 12063552

6

Anti-tumor efficacy of a novel antisense anti-MDM2 mixed-backbone oligonucleotide in human colon cancer models: p53-dependent and p53-independent mechanisms.

Wang H, Nan L, Yu D, Lindsey JR, Agrawal S, Zhang R. Wang H, et al. Among authors: zhang r. Mol Med. 2002 Apr;8(4):185-99. Mol Med. 2002. PMID: 12149568 Free PMC article.

7

Antisense oligonucleotides targeting RI alpha subunit of protein kinase A. In vitro and in vivo anti-tumor activity and pharmacokinetics.

Zhang R, Wang H. Zhang R, et al. Methods Mol Med. 2003;75:637-54. Methods Mol Med. 2003. PMID: 12407769 No abstract available.

8

Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.

Wang H, Yu D, Agrawal S, Zhang R. Wang H, et al. Among authors: zhang r. Prostate. 2003 Feb 15;54(3):194-205. doi: 10.1002/pros.10187. Prostate. 2003. PMID: 12518324

9

Antisense oligonucleotide inhibitors of MDM2 oncogene expression.

Zhang R, Wang H. Zhang R, et al. Methods Mol Med. 2003;85:205-22. doi: 10.1385/1-59259-380-1:205. Methods Mol Med. 2003. PMID: 12710210 Review. No abstract available.

10

Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles.

Kandimalla ER, Bhagat L, Wang D, Yu D, Zhu FG, Tang J, Wang H, Huang P, Zhang R, Agrawal S. Kandimalla ER, et al. Among authors: zhang r. Nucleic Acids Res. 2003 May 1;31(9):2393-400. doi: 10.1093/nar/gkg343. Nucleic Acids Res. 2003. PMID: 12711684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,876 results

Search Page

Filters